Related Experiment Video
Updated: Mar 26, 2026

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
Published on: December 30, 2016
Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner
Lianjun Zhang1, Benjamin O Tschumi1, Isabel C Lopez-Mejia2
1Ludwig Center for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland.
Abstract:
Upon infection, antigen-specific naive CD8 T cells are activated and differentiate into short-lived effector cells (SLECs) and memory precursor cells (MPECs). The underlying signaling pathways remain largely unresolved. We show that Rictor, the core component of mammalian target of rapamycin complex 2 (mTORC2), regulates SLEC and MPEC commitment. Rictor deficiency favors memory formation and increases IL-2 secretion capacity without dampening effector functions. Moreover, mTORC2-deficient memory T cells mount more potent recall responses. Enhanced memory formation in the absence of mTORC2 was associated with Eomes and Tcf-1 upregulation, repression of T-bet, enhanced mitochondrial spare respiratory capacity, and fatty acid oxidation. This transcriptional and metabolic reprogramming is mainly driven by nuclear stabilization of Foxo1. Silencing of Foxo1 reversed the increased MPEC differentiation and IL-2 production and led to an impaired recall response of Rictor KO memory T cells. Therefore, mTORC2 is a critical regulator of CD8 T cell differentiation and may be an important target for immunotherapy interventions.
Insights
Mammalian target of rapamycin complex 2 (mTORC2) regulates CD8 T cell differentiation. Its deficiency enhances memory formation and recall responses, offering potential immunotherapy targets.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- CD8 T cell activation upon infection leads to short-lived effector cells (SLECs) and memory precursor cells (MPECs).
- The signaling pathways governing this differentiation are not fully understood.
- Mammalian target of rapamycin complex 2 (mTORC2) is a key signaling complex.
Purpose of the Study:
- To investigate the role of Rictor, a core component of mTORC2, in CD8 T cell differentiation.
- To elucidate the molecular mechanisms by which mTORC2 influences T cell fate.
Main Methods:
- Utilized Rictor knockout (KO) models.
- Analyzed CD8 T cell differentiation, effector functions, and memory formation.
- Assessed gene expression (Eomes, Tcf-1, T-bet), mitochondrial respiration, fatty acid oxidation, and Foxo1 activity.
Main Results:
- Rictor deficiency promoted memory precursor cell (MPEC) commitment over short-lived effector cell (SLEC) differentiation.
- mTORC2-deficient CD8 T cells showed enhanced IL-2 secretion, potent recall responses, and improved effector functions.
- Key findings included Eomes/Tcf-1 upregulation, T-bet repression, enhanced mitochondrial function, and Foxo1 nuclear stabilization.
Conclusions:
- mTORC2 is a critical regulator of CD8 T cell differentiation, favoring effector cell fate.
- Rictor deficiency enhances memory formation and recall responses through Foxo1-mediated transcriptional and metabolic reprogramming.
- mTORC2 inhibition represents a potential therapeutic strategy for enhancing T cell-based immunotherapies.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cells of the Adaptive Immune Response

